Delxone TZ 125mg/15.6mg Injection
Marketer
Dr. Edwin Lab
Salt Composition
Ceftriaxone (125mg) + Tazobactum (15.6mg)
Overview Delxone TZ 125mg/15.6mg Injection
Combiflox TZ, a 125mg/15.6mg injectable formulation, combats bacterial infections by inhibiting microbial proliferation. Administered only by healthcare professionals, this medication requires adherence to the prescribed dosage schedule. Complete the entire course of treatment, even with symptom improvement, as premature cessation may reduce efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening side effects necessitate immediate medical attention. Allergic reactions (rash, pruritus, edema, dyspnea) demand immediate medical help. Inform your doctor of all concurrent medications, especially if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid driving if drowsiness or dizziness occur. Rest, nutrition, and hydration are vital for optimal recovery. Your physician may order lab tests to monitor treatment response.
Uses of Delxone TZ 125mg/15.6mg Injection
Infections caused by bacteria
Major Benefits of Delxone TZ 125mg/15.6mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Delxone TZ 125mg/15.6mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Delxone TZ 125mg/15.6mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
How Delxone TZ 125mg/15.6mg Injection works:
Ceftriaxone/Tazobactam injection (Delxone TZ 125mg/15.6mg) unites a cephalosporin antibiotic (Ceftriaxone) with a beta-lactamase inhibitor (Tazobactam). Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, vital for bacterial viability. Tazobactam counters bacterial resistance mechanisms, thereby optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Concurrent use of Delxone TZ 125mg/15.6mg Injection and alcohol does not produce adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Delxone TZ (125mg/15.6mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to the fetus; nonetheless, data from human trials remain scarce.
Breast feedingCAUTION
Administering Delxone TZ 125mg/15.6mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily suspended throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Delxone TZ 125mg/15.6mg Injection could induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Delxone TZ 125mg/15.6mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Delxone TZ (125mg/15.6mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Delxone TZ (125mg/15.6mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Delxone TZ 125mg/15.6mg Injection :
Omitting a scheduled dose of Delxone TZ 125mg/15.6mg Injection warrants immediate physician consultation.
Facts to Know About Delxone TZ 125mg/15.6mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective Agents |
3,018 People bought this recently